0.25 mg
Stage previewWeeks 1–4
once-weekly injection · Starting dose
The labeled injection schedule begins at this dose, not at the maintenance dose.
Dose increases depend on the medicine and the prescribed plan, not just the week number. Explore the labeled starting stages and maintenance options below.
This is a label-reference tool, not a calculator for your next dose, restart plan or compounded-vial units. It does not predict side effects or weight loss. Follow your prescriber's instructions and the Medication Guide for your exact product.
Semaglutide injection. This view shows the initial escalation and adult weight-management maintenance options through 2.4 mg.
A prescriber can postpone an increase by four weeks if the current step is not tolerated. For adult weight management, the label also permits 7.2 mg when more weight reduction is clinically indicated after at least four weeks tolerating 2.4 mg. That option, tablets and other indication-specific schedules are not shown in these cards.
Read the Wegovy injection prescribing information (June 2026)Highlighting a stage does not mean it is your prescribed dose. All stages remain visible.
Weeks 1–4
once-weekly injection · Starting dose
The labeled injection schedule begins at this dose, not at the maintenance dose.
Weeks 5–8
once-weekly injection · Escalation step
The next step in the standard schedule. The prescriber may delay escalation for tolerability.
Weeks 9–12
once-weekly injection · Escalation step
Timing follows the prescribed plan. This week range does not predict when side effects will peak.
Weeks 13–16
once-weekly injection · Escalation or maintenance
This is an escalation step and can also be an adult weight-management maintenance dose.
Week 17 onward in the standard schedule
once-weekly injection · Maintenance options
For adult weight management, 2.4 mg is recommended; 1.7 mg is also a maintenance option. The prescriber selects the dose based on response and tolerability.
Source: Wegovy injection label, dosage and administration. Label documents checked October 23, 2026.
The rule is product-specific. These summaries are not a restart plan after a treatment gap. Ask your pharmacist or prescriber when timing or instructions are unclear.
For one missed injection, the label says to take it when the next dose is more than two days away, or skip it when the next dose is less than two days away. Ask a pharmacist about the exact 48-hour boundary rather than guessing. After two or more consecutive missed doses, contact the prescriber: the label calls for restarting escalation at a lower dose.
Original Wegovy injection instructionsThe missed injection can be taken within five days after it was due. If more than five days have passed, skip it and resume on the usual weekly day. Follow the product instructions and ask the prescriber or pharmacist about a longer interruption.
Original Ozempic injection instructionsTake a missed dose within four days (96 hours) after it was due. Beyond that window, skip it and resume the usual weekly day. Leave at least three days (72 hours) between injections, including when changing the weekly day.
Original Zepbound instructionsTake a missed dose within four days (96 hours) after it was due. Beyond that window, skip it and resume the usual weekly day. Leave at least three days (72 hours) between injections, including when changing the weekly day.
Original Mounjaro instructionsSkip the missed tablet and take the next dose the following day. Do not take an extra tablet to make up for it.
Original Rybelsus tablets instructionsNo. These are label-reference stages, not your prescription. Treatment goals, tolerability, delays and missed doses can change the plan. Use your prescriber's instructions; do not increase or restart a medicine because a stage is highlighted here.
No. Maintenance choices and the reasons for increasing differ by product and indication. For example, adult Zepbound weight-management maintenance options are 5, 10 and 15 mg weekly, while its sleep apnea indication uses 10 or 15 mg. The selected product's label explains its conditions.
No. These cards describe the named branded products in milligrams. They do not convert milligrams to milliliters or syringe units. Ask the dispensing pharmacy and prescriber for instructions for your exact prescription and concentration.
No. A labeled dose stage does not establish when you will lose weight, how much you will lose or when symptoms will improve. Read the product's Medication Guide and contact your prescriber about severe or persistent symptoms rather than treating them as an expected phase.
No. Wegovy injection uses time until the next dose; Ozempic injection uses a five-day window after the missed dose. Zepbound and Mounjaro use a four-day window and at least three days between injections. Rybelsus says to skip the missed tablet. See the product-specific summaries and original labels above; ask a pharmacist or prescriber about interruptions or unclear timing.
For broader safety information, read the Medication Guide and our GLP-1 side effects guide. This tool is not a complete safety checklist.
The detailed dosage guide covers the schedules outside this view. Check savings eligibility separately from the prescribed dose.
Our quiz helps narrow program options. It does not choose a medicine or dose, or decide whether treatment is suitable for you.
Explore program optionsIndependent information, not medical advice or a clinician-reviewed dosing plan. Sources are the current manufacturer prescribing information linked above. Other formulations, pediatric plans and compounded prescriptions need their own instructions.
Affiliate partners we feature. We may earn a commission.
Check the medication, commitment and total price for your selected plan.
Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. Published scores have different evidence limits and do not establish better care. See the program comparison and scoring limitations.